Chikugo, Japan

Toshio Kawahara

This inventor holds 4 USPTO granted patents. Top assignees: Mitsubishi Pharma Corporation, Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1999-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshio Kawahara. Retrieved from https://idiyas.com/inventor/toshio-kawahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 107(Granted Patents)


Location History:

  • Fukuoka, JP (1999 - 2002)
  • Chikujo-gun, JP (2001 - 2005)

Company Filing History:


Years Active: 1999-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Toshio Kawahara

Introduction

Toshio Kawahara is a notable inventor based in Chikujo-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on Rho kinase inhibitors. With a total of 4 patents to his name, Kawahara's innovations have the potential to impact various therapeutic areas.

Latest Patents

Kawahara's latest patents focus on a pharmaceutical agent containing Rho kinase inhibitors. These inhibitors are presented as novel therapeutic agents for a range of conditions, including hypertension, angina pectoris, and asthma. Additionally, they serve as suppressive agents for cerebrovascular contraction and therapeutic agents for peripheral circulation disorders. The applications of these inhibitors extend to being anti-cancer drugs, anti-inflammatory agents, immunosuppressants, and therapeutic agents for autoimmune diseases. Furthermore, they are proposed as contraceptives and prophylactic agents for digestive tract infections, osteoporosis, retinopathy, and brain function improvement.

Career Highlights

Throughout his career, Toshio Kawahara has worked with prominent companies in the pharmaceutical industry. He has been associated with Yoshitomi Pharmaceutical Industries, Ltd. and Mitsubishi Pharma Corporation. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.

Collaborations

Kawahara has collaborated with esteemed colleagues, including Masayoshi Uehata and Takashi Ono. These partnerships have likely enhanced the research and development of his patented innovations.

Conclusion

Toshio Kawahara's contributions to the field of pharmaceuticals through his patents on Rho kinase inhibitors demonstrate his commitment to advancing medical science. His work has the potential to provide therapeutic solutions for various health conditions, showcasing the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…